A. Shakeri and C. Adanty, “Romosozumab (sclerostin monoclonal antibody) for the treatment of osteoporosis in postmenopausal women: A review”, J Popl Ther Clin Pharmacol, vol. 27, no. 1, pp. e25-e31, Jan. 2020, doi: 10.15586/jptcp.v27i1.655.